Allison Marie Suqi, APRN

Allison Suqi practices at Greater Baltimore Medical Center in Baltimore, Maryland, part of GBMC HealthCare.

Allison Suqi's NPI, 1518641596, was assigned on June 12, 2023. Allison Suqi holds Florida license 11026785.

Allison Suqi's primary practice is Greater Baltimore Medical Center, at 6701 North Charles Street, Baltimore, MD 21204 in Baltimore County. The practice phone is (443) 849-2000.

Allison Suqi's primary practice is Greater Baltimore Medical Center in Baltimore, Maryland, part of GBMC HealthCare. Allison Suqi is also affiliated with Luminis Health Anne Arundel Medical Center. The medical group on file is Gilchrist. Dmand AI also links Allison Suqi to 1 more hospice and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Allison Suqi practices, 3 sites in all. Vendor and product names are available with a free account.

Nurse practitioner is Allison Suqi's primary specialty in the NPI Registry, under taxonomy code 363L00000X. Allison Suqi is licensed in Florida.

Dmand AI lists hereditary polyneuropathy, neuropathy, non-alzheimer's dementia (chronic) and parkinson's disease among the conditions Allison Suqi treats.

CMS data shows 525 Medicare services from Allison Suqi across 9 procedure codes in 2024, for 195 Medicare patients. Medicare paid $39,873 for them. Every service was in an office.

CMS counts 195 Medicare patients who saw Allison Suqi in 2024. The largest group is 85 and over, with 87 patients. 75% of them have high blood pressure, and 74% have high cholesterol. 16% are also on Medicaid. Their average risk score is 2.50, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Allison Suqi's median patient age at 78, with 59% women.

In 2024, Allison Suqi wrote 351 Medicare Part D claims for 107 patients. 93% of them were for generic drugs. CMS names the drug for 161 of them, across 10 drugs with 11 or more claims each, at $1,590 in total drug cost.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 94 out of 100 for Allison Suqi for performance year 2024, reported as part of a group. Allison Suqi accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

CMS Open Payments shows 21 general payments to Allison Suqi from 14 drug and device companies from 2024 to 2025. Food and beverage make up the largest share, 99% of the total. Amgen Inc. paid the most, $348.